Advertisement
Advertisement
CVAC
CureVac N.V.
2.87
USD-0.08
-2.71%
Dec 18, 14:07 UTC -5
Open
CureVac N.V. Profile
About
Info & Links
CEO
Franz-Werner Haas
Headquarters
T¿bingen, 2M 72076, GERMANY
Industry
Sector
Website
Auditor
Ernst & Young GmbH
Share holders
--
Employees
455
CureVac N.V. Statistics
Valuation Measures
Market Capitalization2
642.54M
Enterprise Value
80.93M
Enterprise Value/EBITDA(ttm)
0.47
Price to Earnings Ratio(ttm)
5.75
Price to Sales(ttm)
1.19
Price to Book(mrq)
0.89
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
-115.31%
Operating Margin(ttm)
20.72%
Profit Margin(ttm)
-347.11%
Return on Equity(ttm)
21.98%
Return on Invested Capital(ttm)
-3.39%
Return on Assets(ttm)
15.72%
Income Statement
Revenue(ttm)
596.40M
Revenue Per Share(ttm)
--
Gross Profit(ttm)
425.33M
EBITDA(ttm)3
173.63M
Net Income Available to Common(ttm)
123.54M
Diluted EPS(ttm)
0.55
Share Statistics
Beta (5Y Monthly)
2.59
52-Week Change
-45.12%
S&P 500 52-Week Change
27.90%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
--
Dividend Yield
0.00%
Float4
0.00
% Held by Insiders
--
% Held by Institutions
17.26%
Balance Sheet
Total Cash(mrq)
610.19M
Total Cash Per Share(mrq)
--
Total Debt(mrq)
44.12M
Total Debt/Equity(mrq)
5.54%
Current Ratio(mrq)
6.20%
Quick Ratio(mrq)
6.19%
Book Value Per Share(mrq)
3.55
Cash Flow
Operating Cash Flow Per Share(ytd)
0.82
Free Cash Flow(ytd)
172.23M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement